Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study.
Saved in:
| Title: | Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study. |
|---|---|
| Authors: | Armstrong AW; Department of Dermatology, University of California Los Angeles, Los Angeles, California., Gooderham MJ; SKiN Centre for Dermatology, Peterborough, Ontario, Canada; Department of Medicine, Queen's University, Kingston, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada., Eyerich K; Department of Dermatology, University of Freiburg, Freiburg, Germany., Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Blauvelt A; Blauvelt Consulting, LLC, Annapolis, Maryland., Hong HC; Probity Medical Research, Waterloo, Ontario, Canada; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada., Edwards RA; Health Services Consulting Corporation, Boxborough, Massachusetts., Bonfanti G; Engineering Ingegneria Informatica, Milan, Italy., Clibborn C; Pfizer Ltd., Tadworth, Surrey, United Kingdom., Biswas P; Clinical Research, Pfizer Inc., New York, New York., Chan G; Inflammation & Immunology, Pfizer Inc., Groton, Connecticut., Feeney C; Pfizer Ltd., Tadworth, Surrey, United Kingdom., Güler E; Inflammation & Immunology, Pfizer Inc., Istanbul, Turkey. Electronic address: erman.guler@pfizer.com. |
| Source: | Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2026 Jun; Vol. 94 (6), pp. 1857-1861. Date of Electronic Publication: 2026 Feb 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41724439 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Armstrong+AW%22">Armstrong AW</searchLink>; Department of Dermatology, University of California Los Angeles, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Gooderham+MJ%22">Gooderham MJ</searchLink>; SKiN Centre for Dermatology, Peterborough, Ontario, Canada; Department of Medicine, Queen's University, Kingston, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Eyerich+K%22">Eyerich K</searchLink>; Department of Dermatology, University of Freiburg, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Reich+K%22">Reich K</searchLink>; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Blauvelt+A%22">Blauvelt A</searchLink>; Blauvelt Consulting, LLC, Annapolis, Maryland.<br /><searchLink fieldCode="AU" term="%22Hong+HC%22">Hong HC</searchLink>; Probity Medical Research, Waterloo, Ontario, Canada; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Edwards+RA%22">Edwards RA</searchLink>; Health Services Consulting Corporation, Boxborough, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bonfanti+G%22">Bonfanti G</searchLink>; Engineering Ingegneria Informatica, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Clibborn+C%22">Clibborn C</searchLink>; Pfizer Ltd., Tadworth, Surrey, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Biswas+P%22">Biswas P</searchLink>; Clinical Research, Pfizer Inc., New York, New York.<br /><searchLink fieldCode="AU" term="%22Chan+G%22">Chan G</searchLink>; Inflammation & Immunology, Pfizer Inc., Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Feeney+C%22">Feeney C</searchLink>; Pfizer Ltd., Tadworth, Surrey, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Güler+E%22">Güler E</searchLink>; Inflammation & Immunology, Pfizer Inc., Istanbul, Turkey. Electronic address: erman.guler@pfizer.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227907132%22">Journal of the American Academy of Dermatology</searchLink> [J Am Acad Dermatol] 2026 Jun; Vol. 94 (6), pp. 1857-1861. <i>Date of Electronic Publication: </i>2026 Feb 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7907132 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201909622%22">01909622 </searchLink><i>NLM ISO Abbreviation: </i>J Am Acad Dermatol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41724439 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jaad.2026.02.066 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1857 Titles: – TitleFull: Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Armstrong AW – PersonEntity: Name: NameFull: Gooderham MJ – PersonEntity: Name: NameFull: Eyerich K – PersonEntity: Name: NameFull: Reich K – PersonEntity: Name: NameFull: Blauvelt A – PersonEntity: Name: NameFull: Hong HC – PersonEntity: Name: NameFull: Edwards RA – PersonEntity: Name: NameFull: Bonfanti G – PersonEntity: Name: NameFull: Clibborn C – PersonEntity: Name: NameFull: Biswas P – PersonEntity: Name: NameFull: Chan G – PersonEntity: Name: NameFull: Feeney C – PersonEntity: Name: NameFull: Güler E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1097-6787 Numbering: – Type: volume Value: 94 – Type: issue Value: 6 Titles: – TitleFull: Journal of the American Academy of Dermatology Type: main |
| ResultId | 1 |
